Rubius Therapeutics (United States)
0 sources
Financials
0001709401-23-000005Summary
Rubius Therapeutics (United States) is a business[1].
Key Facts
- Rubius Therapeutics (United States) is in the country of United States[2].
- Rubius Therapeutics (United States) is in the country of US[3].
- Rubius Therapeutics (United States)'s instance of is recorded as business[4].
- January 1, 2013 marks the founding of Rubius Therapeutics (United States)[5].
- Rubius Therapeutics (United States)'s coordinate location is recorded as {'globe': 'http://www.wikidata.org/entity/Q2', 'altitude': None, 'latitude': 42.367837, 'longitude': -71.090265, 'precision': 1e-06}[6].
- Rubius Therapeutics (United States)'s official website is recorded as https://www.rubiustx.com/[7].
- Rubius Therapeutics (United States)'s legal form is recorded as Delaware corporation[8].
- Rubius Therapeutics (United States)'s legal form is recorded as XTIQ[9].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300ER84PB0QV6HZ76[10]
-
Registered legal name: Rubius Therapeutics, INC.[11]
-
Legal jurisdiction: US-DE[12]
-
GLEIF entity category: GENERAL[13]
-
Legal form (ISO 20275 ELF): XTIQ[14]
-
Entity status: ACTIVE[15]
-
LEI registration status: LAPSED[16]
-
LEI first registered: 2018-07-03[17]
-
LEI last updated: 2023-08-04[18]
-
LEI next renewal: 2022-06-11[19]
-
Managing LOU: 5493001KJTIIGC8Y1R12[20]
-
Registration authority: RA000602[21]
-
Authority entity ID: 5325688[22]
-
Conformity flag: NON_CONFORMING[23]
Body
Founding
January 1, 2013 marks the founding of Rubius Therapeutics (United States)[5].